Peptide ProvidersDirect
RegenesisMD logo
Unclaimed12 services cataloged

RegenesisMD

Raleigh, NC · Telehealth available

Visit provider website ↗

Provider overview

About RegenesisMD

RegenesisMD publishes a North Raleigh clinic address and identifies Bhavna Vaidya, MD, as founder and medical director. Its official peptide page explicitly describes peptide therapies as compounded, investigational and/or off-label, and not FDA-approved for the promoted indications. Telehealth is limited on the reviewed source to follow-up for established patients in North Carolina.

At a glance

Market role
Direct patient-care provider
Care model
Telehealth and In person
Coverage
1 listed jurisdictions
Pharmacy pathway
Not publicly established
Medical weight managementHormone healthLongevity medicineMetabolic healthLaboratory testing

503A and 503B labels describe statutory compounding pathways or public relationships. They do not mean a compounded drug is FDA-approved or that FDA endorses a facility.

Service catalog

Programs and services

Services advertised on the provider’s public website, organized by area of care.

12 cataloged
01

Provider-advertised recovery peptides

Service 01

BPC-157

RegenesisMD advertises BPC-157 within supervised recovery-oriented protocols and labels its peptide therapies investigational or off-label.

View provider source
Service 02

TB-500

TB-500 is named in the clinic's public peptide catalog; inclusion does not establish approval, safety, or effectiveness.

View provider source
02

Provider-advertised growth-hormone peptides

Service 01

Sermorelin

Sermorelin is listed in a provider-supervised growth-hormone optimization pathway.

View provider source
Service 02

CJC-1295 / Ipamorelin

The combination is named in the clinic's public peptide materials and remains subject to clinical screening.

View provider source
03

Provider-advertised metabolic peptides

Service 01

MOTS-C

MOTS-C is listed in the clinic's metabolic peptide catalog without implying regulatory approval or expected results.

View provider source
Service 02

Tesamorelin blends

The clinic advertises tesamorelin-related blends; approved indications must not be generalized to advertised uses.

View provider source
04

Metabolic health

Service 01

Semaglutide and tirzepatide programs

Physician-supervised GLP-1 and GIP/GLP-1 weight-management pathways are listed with ongoing monitoring.

View provider source
05

Infusion services

Service 01

NAD+ IV therapy

NAD+ IV therapy is advertised at the Raleigh clinic as part of its wellness catalog.

View provider source
06

Hormone health

Service 01

Hormone optimization

BHRT and testosterone optimization are listed as lab-guided services for women and men.

View provider source
07

Testing and ongoing care

Service 01

Functional-medicine laboratory testing

The clinic advertises advanced lab work and health screening to inform individualized planning.

View provider source
Service 02

Established-patient telehealth follow-up

Telehealth follow-ups are explicitly described for established patients throughout North Carolina.

View provider source
08

Regenerative care

Service 01

PRP, stem-cell, and joint procedures

The clinic advertises PRP, joint injections, and stem-cell-related services while noting investigational status for orthopedic stem-cell use.

View provider source
Important: Inclusion does not establish availability for every patient or state, regulatory status, clinical appropriateness, safety, or effectiveness.

Evidence

Sources reviewed

Logo reproduced from the provider’s official website for identification. Logo source ↗

These links support the public facts recorded here. Provider-published information is not an independent endorsement.